Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).
2026 · 3rd Quarter (July 1 - Sep 30)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Filed by ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC).
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Filing UUID
- dfb8e850-2331-467c-ad23-a3ca408c07e8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to drug pricing, generally; 340B Drug Pricing Program; most favored nation drug pricing; Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization
Pharmacy Benefit Manager reform.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.